Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 185Neoplasms 181Carcinoma, Non-Small-Cell Lung 153Prostatic Neoplasms 120Colorectal Neoplasms 111Lung Neoplasms 97Ovarian Neoplasms 83Neoplasm Metastasis 82Multiple Myeloma 76Pancreatic Neoplasms 75Leukemia, Myeloid, Acute 65Endometrial Neoplasms 52Stomach Neoplasms 48Squamous Cell Carcinoma of Head and Neck 47Melanoma 47Recurrence 46Lymphoma 45Hematologic Neoplasms 44Glioblastoma 44Carcinoma, Renal Cell 44Brain Neoplasms 44Carcinoma, Hepatocellular 42Urinary Bladder Neoplasms 41Precursor Cell Lymphoblastic Leukemia-Lymphoma 39Lymphoma, Non-Hodgkin 39Leukemia, Lymphocytic, Chronic, B-Cell 38Triple Negative Breast Neoplasms 35Glioma 35Small Cell Lung Carcinoma 34Sarcoma 34

Interventions

enzalutamide 1abiraterone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Bites and Stings × 30 days × Clear all
NCT04221542 2026-05-29

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

Amgen

Phase 1 Recruiting
479 enrolled
Genitourinary

Bites and Stings, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡